The abstract is read at the publisher; the summary is JClub's.
In cardiac fibroblast-specific YTHDF1-deficient mice, p66shc depletion reduces micronuclear rupture and mitochondrial ROS, and alleviates isoproterenol/transverse aortic constriction–induced cardiac fibrosis.
- Why it matters: Micronuclear rupture during cardiac fibrosis is linked to reactive oxygen species, but the molecular pathway connecting micronuclear damage to fibrotic progression is unclear.
- What they did: Mice received AAV9 periostin-promoter targeting to overexpress p66shc or knock down YTHDF1, with or without the m6A inhibitor 3-deoxyadenosine; histology and molecular assays tested p66shc mRNA stability and micronuclear rupture, and human atrial fibrillation tissue was analyzed for validation.
- The result: During fibrosis, p66shc upregulation correlated with elevated m6A on p66shc mRNA, and YTHDF1 recognition of this m6A site increased p66shc stability/translation; in human atrial fibrillation hearts, higher YTHDF1 and p66shc associated with micronuclear rupture, mitochondrial ROS, fibroblast pyroptosis, and cardiac fibrosis.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.